DexCom Research and Development Expenses 2010-2024 | DXCM
DexCom annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- DexCom research and development expenses for the quarter ending September 30, 2024 were $0.135B, a 3.04% increase year-over-year.
- DexCom research and development expenses for the twelve months ending September 30, 2024 were $549M, a 12.96% increase year-over-year.
- DexCom annual research and development expenses for 2023 were $0.506B, a 4.46% increase from 2022.
- DexCom annual research and development expenses for 2022 were $0.484B, a 19.86% decline from 2021.
- DexCom annual research and development expenses for 2021 were $0.604B, a 67.88% increase from 2020.
| DexCom Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $506 |
| 2022 | $484 |
| 2021 | $604 |
| 2020 | $360 |
| 2019 | $274 |
| 2018 | $417 |
| 2017 | $185 |
| 2016 | $156 |
| 2015 | $138 |
| 2014 | $69 |
| 2013 | $45 |
| 2012 | $38 |
| 2011 | $30 |
| 2010 | $23 |
| 2009 | $14 |
| DexCom Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $135 |
| 2024-06-30 | $136 |
| 2024-03-31 | $142 |
| 2023-12-31 | $136 |
| 2023-09-30 | $131 |
| 2023-06-30 | $119 |
| 2023-03-31 | $119 |
| 2022-12-31 | $116 |
| 2022-09-30 | $110 |
| 2022-06-30 | $122 |
| 2022-03-31 | $136 |
| 2021-12-31 | $237 |
| 2021-09-30 | $129 |
| 2021-06-30 | $129 |
| 2021-03-31 | $109 |
| 2020-12-31 | $119 |
| 2020-09-30 | $88 |
| 2020-06-30 | $80 |
| 2020-03-31 | $73 |
| 2019-12-31 | $79 |
| 2019-09-30 | $67 |
| 2019-06-30 | $69 |
| 2019-03-31 | $59 |
| 2018-12-31 | $275 |
| 2018-09-30 | $50 |
| 2018-06-30 | $47 |
| 2018-03-31 | $45 |
| 2017-12-31 | $49 |
| 2017-09-30 | $43 |
| 2017-06-30 | $45 |
| 2017-03-31 | $48 |
| 2016-12-31 | $44 |
| 2016-09-30 | $44 |
| 2016-06-30 | $36 |
| 2016-03-31 | $32 |
| 2015-12-31 | $29 |
| 2015-09-30 | $65 |
| 2015-06-30 | $24 |
| 2015-03-31 | $20 |
| 2014-12-31 | $22 |
| 2014-09-30 | $19 |
| 2014-06-30 | $15 |
| 2014-03-31 | $15 |
| 2013-12-31 | $13 |
| 2013-09-30 | $12 |
| 2013-06-30 | $11 |
| 2013-03-31 | $9 |
| 2012-12-31 | $9 |
| 2012-09-30 | $10 |
| 2012-06-30 | $10 |
| 2012-03-31 | $9 |
| 2011-12-31 | $8 |
| 2011-09-30 | $8 |
| 2011-06-30 | $7 |
| 2011-03-31 | $6 |
| 2010-12-31 | $7 |
| 2010-09-30 | $6 |
| 2010-06-30 | $5 |
| 2010-03-31 | $5 |
| 2009-12-31 | $4 |
| 2009-09-30 | $3 |
| 2009-06-30 | $3 |
| 2009-03-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $26.799B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.078B | 26.12 |
| Intuitive Surgical (ISRG) | United States | $183.628B | 96.01 |
| Alcon (ALC) | Switzerland | $45.117B | 31.76 |
| IQVIA Holdings (IQV) | United States | $40.157B | 22.12 |
| Edwards Lifesciences (EW) | United States | $39.608B | 24.62 |
| IDEXX Laboratories (IDXX) | United States | $34.672B | 40.83 |
| Waters (WAT) | United States | $22.960B | 33.95 |
| STERIS (STE) | Ireland | $22.437B | 25.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.922B | 0.00 |
| Hologic (HOLX) | United States | $18.696B | 19.73 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 12.70 |
| Sysmex ADR (SSMXY) | Japan | $11.851B | 37.16 |
| Globus Medical (GMED) | United States | $11.200B | 28.52 |
| Teleflex (TFX) | United States | $9.378B | 14.96 |
| Penumbra (PEN) | United States | $8.969B | 87.86 |
| Masimo (MASI) | United States | $8.917B | 43.43 |
| Glaukos (GKOS) | United States | $7.755B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.126B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.542B | 25.75 |
| Inari Medical (NARI) | United States | $3.119B | 0.00 |
| TransMedics (TMDX) | United States | $2.898B | 91.86 |
| LivaNova (LIVN) | United Kingdom | $2.829B | 16.33 |
| Veracyte (VCYT) | United States | $2.811B | 85.09 |
| Nihon Kohden (NHNKY) | Japan | $2.519B | 15.68 |
| Tandem Diabetes Care (TNDM) | United States | $2.242B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.227B | 18.14 |
| Integra LifeSciences Holdings (IART) | United States | $2.060B | 10.77 |
| RxSight (RXST) | United States | $2.024B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.257B | 0.00 |
| Artivion (AORT) | United States | $1.233B | 113.23 |
| Pulse Biosciences (PLSE) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.025B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.963B | 16.37 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.726B | 18.33 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| IRadimed (IRMD) | United States | $0.712B | 38.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| AxoGen (AXGN) | United States | $0.672B | 0.00 |
| SiBone (SIBN) | United States | $0.669B | 0.00 |
| Paragon 28 (FNA) | United States | $0.605B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.485B | 0.00 |
| CVRx (CVRX) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.99 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 19.57 |
| Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
| NeuroPace (NPCE) | United States | $0.228B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| 908 Devices (MASS) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 16.32 |
| EDAP TMS S.A (EDAP) | France | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |